Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
35.76%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 1.5Close
$ 0.68 - $ 3.23 52-Week Range
Ticker Information
Ticker
FATECompany Name
FATE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQFATE THERAPEUTICS INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
FATE - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 3.03M | 35.76% | $ 8.47M |
| 3/31/2025 | $ 1.84M | 13.8% | $ 13.34M |
| 12/31/2024 | $ 730K | 5.36% | $ 13.63M |
| 9/30/2024 | $ 813K | 6.05% | $ 13.45M |
| 6/30/2024 | $ 883K | 7.17% | $ 12.32M |
| 3/31/2024 | $ 3.03M | 46.79% | $ 6.48M |
| 12/31/2023 | $ 6.15M | 9.68% | $ 63.53M |
| 9/30/2023 | $ 12.65M | 11.91% | $ 106.21M |
| 6/30/2023 | $ 20.76M | 17.41% | $ 119.25M |
| 3/31/2023 | $ 28.69M | 20.96% | $ 136.87M |
Key Performance Insights, Last 5 Years
- FATE THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx % stands at 28.63%.
- Over the past 5 years, FATE THERAPEUTICS INC's average CapEx % has been 35.49%.
- The median CapEx % for FATE THERAPEUTICS INC during this period was 24.79%
- FATE THERAPEUTICS INC reached its highest CapEx % over the past 5 years at 90.79%.
- The lowest CapEx % recorded by FATE THERAPEUTICS INC in the same timeframe 5.36%
FATE THERAPEUTICS INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for FATE THERAPEUTICS INC is calculated as follows: CapEx [ $ 5.25M ] / Revenues [ $ 18.34M ]
(=) CapEx % [ 28.63% ] FATE - Capital Expenditures Margin, Last 5 years
5.36%
Minimum
Dec 31, 2024
90.79%
Maximum
Dec 31, 2021
35.49%
Average
24.79%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.47% with a standard deviation of 3.28%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.47% |
| median | 2.43% |
| std | 3.28% |